In a report released today, Luke Sergott from Barclays maintained a Buy rating on Sotera Health (SHC – Research Report), with a price target of $16.00. The company’s shares closed yesterday at ...

Sotera Health ( NASDAQ:SHC ) Full Year 2024 Results Key Financial Results Revenue: US$1.10b (up 4.9% from FY 2023). Net... Sotera Health Co (SHC) reports its 19th consecutive year of revenue ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

After hours: March 21 at 4:33:19 PM EDT Loading Chart for SHC ...

In a report released yesterday, Sean Dodge from RBC Capital reiterated a Buy rating on Sotera Health (SHC – Research Report), with a price target of $17.00. The company’s shares closed ...

Whether you're not feeling well, need a physical or require a vaccination, the Student Health Center is here for you. Located in Gosiger Hall, we are staffed by a team of board-certified primary care ...

Learn more here. Operator Good morning, and welcome to the Sotera Health fourth quarter and full-year 2024 conference call.

SHC opened at $13.73 on Wednesday. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The company has a market cap of $3.89 billion, a P/E ratio of 54.92 and a beta of 1.91.